Effect of Yangxinshi Tablet on Exercise Tolerance in Patients With Chronic Coronary Syndrome(MET STUDY)

PHASE4RecruitingINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

November 8, 2023

Primary Completion Date

June 30, 2025

Study Completion Date

December 31, 2025

Conditions
Chronic Coronary Syndrome
Interventions
DRUG

Yangxinshi tablet

The treatment group was given Yangxinshi tablets (3 tablets/time and 3 times/day). The treatment period was 24 weeks.

DRUG

Yangxinshi tablet simulants

The control group was given Yangxinshi tablet simulants (3 tablets/time and 3 times/day).The treatment period was 24 weeks.

Trial Locations (6)

Unknown

RECRUITING

China-Japan Friendship Hospital, Beijing

NOT_YET_RECRUITING

Dongzhimen Hospital Beijing University of Chinese Medicine, Beijing

NOT_YET_RECRUITING

The First Affiliated Hospital of Chongqing Medical University, Chongqing

NOT_YET_RECRUITING

Guangdong Provincial Hospital of Chinese Medicine, Guangzhou

RECRUITING

The First Hospital of Hebei Medical University, Shijiazhuang

RECRUITING

The First Affiliated Hospital of Henan University of CM, Zhengzhou

All Listed Sponsors
lead

Dongzhimen Hospital, Beijing

OTHER